Cargando…
ELTD1 as a multi-focal target for malignant gliomas: preclinical studies
BACKGROUND: Glioblastoma (GBM) is the most aggressive malignant primary brain tumor in adults. These high-grade gliomas undergo unregulated vascular angiogenesis, migration and cell proliferation allowing the tumor cells to evade cell-cycle checkpoints and apoptotic pathways. The Epidermal growth fa...
Autores principales: | Zalles, Michelle, Smith, Nataliya, Saunders, Debra, Guzman, Mayra, Lerner, Megan, Fung, Kar-Ming, Babu, Anish, Battiste, James, Chung, Junho, Hwang, Kyusang, Jin, Junyeong, Towner, Rheal A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541707/ https://www.ncbi.nlm.nih.gov/pubmed/34704036 http://dx.doi.org/10.1093/noajnl/vdab132 |
Ejemplares similares
-
A tale of two multi‐focal therapies for glioblastoma: An antibody targeting ELTD1 and nitrone‐based OKN‐007
por: Zalles, Michelle, et al.
Publicado: (2021) -
Assessment of an scFv Antibody Fragment Against ELTD1 in a G55 Glioblastoma Xenograft Model()()
por: Zalles, Michelle, et al.
Publicado: (2020) -
Optimized monoclonal antibody treatment against ELTD1 for GBM in a G55 xenograft mouse model
por: Zalles, Michelle, et al.
Publicado: (2019) -
Novel approaches to combat chemoresistance against glioblastomas
por: Towner, Rheal A., et al.
Publicado: (2020) -
OKlahoma Nitrone-007: novel treatment for diffuse intrinsic pontine glioma
por: Thomas, Lincy, et al.
Publicado: (2020)